Your account is not claimed yet. You can sign up with ORCID to claim your account.

Andrew W Daman (Andrew Daman)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Transcription Factor

Acute Lymphoblastic Leukemia

Top Venues

The Journal of experimental medicine

Weill Cornell Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Weill Cornell Medical College Aug 20o 2017

United States

PHD :: Immunology and Microbial Pathogenesis

Publications

Christopher M Bourne, Sung Soo Mun, Tao Dao, Zita E H Aretz, Zaki Molvi, Ron S Gejman, Andrew W Daman, Katsuyoshi Takata, Christian Steidl, Martin G Klatt, David A Scheinberg
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment. Blood advances 6 (14) (2022)
Andrew W Daman, Steven Zvi Josefowicz
Epigenetic and transcriptional control of interferon-β. The Journal of experimental medicine 218 (9) (2021)
Shannon K Oda, Andrew W Daman, Nicolas M Garcia, Felecia Wagener, Thomas M Schmitt, Xiaoxia Tan, Aude G Chapuis, Philip D Greenberg
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia. Blood 130 (22) (2017)